Specialized Imaging Technique Detects Most Clinically Relevant Prostate Cancers
How Does mpMRI Change the Diagnostic Pathway?
Medical University of Vienna researchers have found that a specialized imaging method significantly improves detection of aggressive prostate cancers compared to standard approaches. The study, conducted in September 2026, focused on men with elevated prostate-specific antigen (PSA) levels who required further investigation. By using advanced imaging, clinicians were able to identify a higher proportion of tumors needing immediate treatment while reducing unnecessary biopsies. This development addresses a key limitation of PSA testing, which often flags benign conditions and leads to overdiagnosis.
Health news
Vegan Diets May Reduce Gut Bacteria Diversity, Study Finds
Music with beats cuts stress hormone more than pink noise
Epigenetic Shifts Can Trigger Liver Cancer Without DNA Damage
Blood Clots and Brain Tumors Linked by Overactive PlateletsThe technique, known as multiparametric magnetic resonance imaging (mpMRI), combines multiple MRI sequences to provide detailed views of prostate tissue. Researchers analyzed data from over 500 patients with suspected prostate cancer based on elevated PSA. Results showed mpMRI detected approximately 85% of clinically significant cancers—defined as tumors with a Gleason score of 7 or higher—compared to about 60% detected through systematic biopsy alone. The imaging also helped distinguish between indolent tumors unlikely to cause harm and aggressive forms requiring intervention. Lead researcher Dr. Anna Berger noted that the method allows for more targeted biopsies, increasing diagnostic accuracy while minimizing patient discomfort and risk of infection.
Can This Technology Reduce Overreatment in Prostate Cancer?
By integrating mpMRI early in the evaluation process, clinicians can prioritize biopsies for suspicious lesions identified on scans. This approach reduces the number of random tissue samples needed and focuses on areas most likely to harbor dangerous cancers. In the Vienna study, nearly 40% of patients with elevated PSA avoided biopsy altogether because their mpMRI scans showed no suspicious lesions. For those who did undergo biopsy, the cancer detection rate per sample taken was significantly higher. The technique also assists in staging, helping determine whether cancer remains confined to the prostate or has begun to spread—a critical factor in treatment planning.
One of the major benefits highlighted in the study is the potential to decrease overtreatment of low-risk cancers. By better identifying which tumors are unlikely to progress, mpMRI supports active surveillance strategies instead of immediate surgery or radiation. Researchers observed that among men initially suspected of having cancer based on PSA, mpMRI correctly classified about half as having only low-risk disease. This enables patients to avoid side effects such as incontinence and erectile dysfunction associated with aggressive treatments. The Medical University of Vienna team recommends incorporating mpMRI into clinical guidelines for men with elevated PSA before proceeding to biopsy, particularly in cases where initial results are ambiguous.
What is a clinically significant prostate cancer? It refers to tumors with a Gleason score of 7 or higher, or those showing certain molecular markers, that are likely to grow and spread without intervention. These cancers require active treatment rather than monitoring.
Frequently Asked Questions
How does elevated PSA relate to cancer risk? While prostate-specific antigen levels can rise due to cancer, they also increase with benign conditions like inflammation or prostate enlargement. Therefore, elevated PSA alone cannot confirm cancer and requires further diagnostic steps such as imaging or biopsy.
Is mpMRI available outside of research settings? Yes, multiparametric MRI is increasingly used in hospitals and specialized clinics worldwide, though access may vary by region and healthcare system. It is typically recommended when PSA levels are elevated and a digital rectal exam raises concern.